Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Aspire-Lakewood Holdings, Inc. - Warrant (NQ:ASBPW)

0.0131 UNCHANGED

Streaming Delayed Price Updated: 11:07 AM EDT, Sep 8, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	0.0131
Bid (Size)	0.0132 (36,000)
Ask (Size)	0.0198 (21,900)
Prev. Close	0.0131
Today's Range	0.0131 - 0.0131
52wk Range	0.0100 - 0.0450
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Aspire-Lakewood Holdings Board Approves $10 Million Share Repurchase Program

September 09, 2026

Brings total authorized repurchase to $10 million Reflects leadership's view that Aspire-Lakewood's share price does not reflect the Company's financial strength or long-term growth opportunity...

From Aspire Biopharma Holdings, Inc.

Via ACCESS Newswire

Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc.

September 08, 2026

From Aspire Biopharma Holdings, Inc.

Via ACCESS Newswire

Performance

YTD	-29.6%	-29.6%
1 Month	-34.5%	-34.5%
3 Month	-13.2%	-13.2%
6 Month	-29.2%	-29.2%
1 Year	-65.5%	-65.5%

More News

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th

August 13, 2026

From Aspire Biopharma Holdings, Inc.

Via ACCESS Newswire

Aspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue

August 10, 2026

From Aspire Biopharma Holdings, Inc.

Via ACCESS Newswire

Freestyle Motocross Legend Jarryd McNeil Named Newest Sponsored Athlete for Aspire Biopharma's BUZZ BOMB(TM)

July 20, 2026

From Aspire Biopharma Holdings, Inc.

Via ACCESS Newswire

Aspire Biopharma's BUZZ BOMB(TM) Launches on Amazon, Introducing Next-Generation Caffeine Stick Packs

June 24, 2026

From Aspire Biopharma Holdings, Inc.

Via ACCESS Newswire

Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue

June 12, 2026

Via ACCESS Newswire

Aspire Biopharma Issues Shareholder Letter

May 28, 2026

Via ACCESS Newswire

Aspire Biopharma's BUZZ BOMBTM Partners with EoS Fitness to Empower High-Performance Lifestyles for Millions of Members

May 27, 2026

Via ACCESS Newswire

Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio

May 07, 2026

Via ACCESS Newswire

Aspire Biopharma Announces $5.0 Million Share Repurchase Program

April 27, 2026

Via ACCESS Newswire

Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition

April 20, 2026

Via ACCESS Newswire

Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo

April 17, 2026

Via ACCESS Newswire

Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue

April 16, 2026

Via ACCESS Newswire

Aspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion

April 15, 2026

Via ACCESS Newswire

Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion

March 19, 2026

Via ACCESS Newswire

Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director

March 17, 2026

Via ACCESS Newswire

Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026

March 12, 2026

Via ACCESS Newswire

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack

March 10, 2026

Via ACCESS Newswire

Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief

March 03, 2026

Via ACCESS Newswire

Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship

February 25, 2026

Via ACCESS Newswire

Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements

February 20, 2026

Via ACCESS Newswire

Aspire Biopharma's Buzz Bomb Caffeine Company Names ChicExecs as Public Relations Agency of Record

February 19, 2026

Via ACCESS Newswire

Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))

February 17, 2026

Via ACCESS Newswire

Aspire Biopharma Announces the Appointment of New Member to Its Board of Directors

February 13, 2026

Via ACCESS Newswire

Frequently Asked Questions

Is Aspire-Lakewood Holdings, Inc. - Warrant publicly traded?

Yes, Aspire-Lakewood Holdings, Inc. - Warrant is publicly traded.

What exchange does Aspire-Lakewood Holdings, Inc. - Warrant trade on?

Aspire-Lakewood Holdings, Inc. - Warrant trades on the Nasdaq Stock Market

What is the ticker symbol for Aspire-Lakewood Holdings, Inc. - Warrant?

The ticker symbol for Aspire-Lakewood Holdings, Inc. - Warrant is ASBPW on the Nasdaq Stock Market

What is the current price of Aspire-Lakewood Holdings, Inc. - Warrant?

The current price of Aspire-Lakewood Holdings, Inc. - Warrant is 0.0131

When was Aspire-Lakewood Holdings, Inc. - Warrant last traded?

The last trade of Aspire-Lakewood Holdings, Inc. - Warrant was at 09/08/26 11:07 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.